A first-in-human phase I trial of NB003, a potent and selective KIT/PDGFRa inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST) Meeting Abstract


Authors: Chi, P.; Shen, L.; Li, J.; Zhang, J.; Hu, K.; Zhang, L.; Xu, Y.
Abstract Title: A first-in-human phase I trial of NB003, a potent and selective KIT/PDGFRa inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST)
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S1031
Language: English
ACCESSION: WOS:001087480202580
DOI: 10.1016/j.annonc.2023.09.1145
PROVIDER: wos
Notes: Meeting Abstract: 1916MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ping Chi
    172 Chi